These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 27637018)

  • 1. A CRISPR Way to Change Genes.
    Shabto J
    J Pediatr Ophthalmol Strabismus; 2016 Sep; 53(5):268-9. PubMed ID: 27637018
    [No Abstract]   [Full Text] [Related]  

  • 2. Ji Luo Elucidates the CRISPR Gene Editing Technology, and How It May Affect Cancer Therapy in the Future.
    Luo J
    Oncology (Williston Park); 2016 Oct; 30(10):879. PubMed ID: 27753053
    [No Abstract]   [Full Text] [Related]  

  • 3. Genome editing: The efficient tool CRISPR-Cpf1.
    Mahfouz MM
    Nat Plants; 2017 Mar; 3():17028. PubMed ID: 28260792
    [No Abstract]   [Full Text] [Related]  

  • 4. Could CRISPR be the solution for gene editing's Gordian knot?
    Fang H; Wang W
    Cell Biol Toxicol; 2016 Dec; 32(6):465-467. PubMed ID: 27614448
    [No Abstract]   [Full Text] [Related]  

  • 5. Genome Editing in Retinal Diseases using CRISPR Technology.
    Yiu G
    Ophthalmol Retina; 2018 Jan; 2(1):1-3. PubMed ID: 31047294
    [No Abstract]   [Full Text] [Related]  

  • 6. Special Issue on the Chemical Biology of CRISPR.
    Weidmann AG; Choudhary A
    ACS Chem Biol; 2018 Feb; 13(2):283-284. PubMed ID: 29448763
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clustered regularly interspaced short palindromic repeat associated protein genes cas1 and cas2 in Shigella].
    Xue Z; Wang Y; Duan G; Wang P; Wang L; Guo X; Xi Y
    Zhonghua Liu Xing Bing Xue Za Zhi; 2014 May; 35(5):581-4. PubMed ID: 25059373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Application of CRISPR/Cas9 genome editing to the study and treatment of disease.
    Pellagatti A; Dolatshad H; Valletta S; Boultwood J
    Arch Toxicol; 2015 Jul; 89(7):1023-34. PubMed ID: 25827103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Progress of genome engineering technology via clustered regularly interspaced short palindromic repeats--a review].
    Li H; Qiu S; Song H
    Wei Sheng Wu Xue Bao; 2013 Oct; 53(10):1025-30. PubMed ID: 24409757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent Progress in CRISPR/Cas9 Technology.
    Mei Y; Wang Y; Chen H; Sun ZS; Ju XD
    J Genet Genomics; 2016 Feb; 43(2):63-75. PubMed ID: 26924689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Right of admission reserved, no matter the path.
    Mojica FJ; Díez-Villaseñor C
    Trends Microbiol; 2013 Sep; 21(9):446-8. PubMed ID: 23810125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene drive overdrive.
    Nat Biotechnol; 2015 Oct; 33(10):1019-21. PubMed ID: 26448078
    [No Abstract]   [Full Text] [Related]  

  • 13. CRISPR/Cas9 system as an innovative genetic engineering tool: Enhancements in sequence specificity and delivery methods.
    Jo YI; Suresh B; Kim H; Ramakrishna S
    Biochim Biophys Acta; 2015 Dec; 1856(2):234-43. PubMed ID: 26434948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. "CRISPR" validation of recessive brain cancer genes in vivo.
    Zuckermann M; Kawauchi D; Gronych J
    Oncotarget; 2015 Jul; 6(20):17865-6. PubMed ID: 26203775
    [No Abstract]   [Full Text] [Related]  

  • 15. The application of genome editing in studying hearing loss.
    Zou B; Mittal R; Grati M; Lu Z; Shu Y; Tao Y; Feng Y; Xie D; Kong W; Yang S; Chen ZY; Liu X
    Hear Res; 2015 Sep; 327():102-8. PubMed ID: 25987504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genome modification by CRISPR/Cas9.
    Ma Y; Zhang L; Huang X
    FEBS J; 2014 Dec; 281(23):5186-93. PubMed ID: 25315507
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CRISPR Outsourcing: Commissioning IHF for Site-Specific Integration of Foreign DNA at the CRISPR Array.
    Wei Y; Terns MP
    Mol Cell; 2016 Jun; 62(6):803-804. PubMed ID: 27315553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CRISPR-Cas9 knockout screening for functional genomics.
    Shen Z; Ou G
    Sci China Life Sci; 2014 Jul; 57(7):733-4. PubMed ID: 25005538
    [No Abstract]   [Full Text] [Related]  

  • 19. Programmable DNA cleavage in vitro by Cas9.
    Karvelis T; Gasiunas G; Siksnys V
    Biochem Soc Trans; 2013 Dec; 41(6):1401-6. PubMed ID: 24256227
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methods in Enzymology. The use of CRISPR/Cas9, ZFNs, and TALENs in generating site-specific genome alterations. Preface.
    Doudna JA; Sontheimer EJ
    Methods Enzymol; 2014; 546():xix-xx. PubMed ID: 25398356
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.